{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T22:32:37Z","timestamp":1790893957698,"version":"4.1.0"},"reference-count":147,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T00:00:00Z","timestamp":1708387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T00:00:00Z","timestamp":1708387200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Grants-in-Aid for Scientific Research","doi-asserted-by":"crossref","award":["18K06956"],"award-info":[{"award-number":["18K06956"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001691","name":"Grants-in-Aid for Scientific Research","doi-asserted-by":"crossref","award":["21K07121"],"award-info":[{"award-number":["21K07121"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001691","name":"Grants-in-Aid for Scientific Research","doi-asserted-by":"crossref","award":["16H06374"],"award-info":[{"award-number":["16H06374"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Project for Cancer Research and Therapeutic Evolution","award":["22ama221104h0001"],"award-info":[{"award-number":["22ama221104h0001"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["In Vitro Cell.Dev.Biol.-Animal"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1007\/s11626-024-00858-7","type":"journal-article","created":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T19:02:26Z","timestamp":1708455746000},"page":"466-481","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Wnt\/\u03b2-catenin signaling pathway in liver biology and tumorigenesis"],"prefix":"10.1007","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1804-264X","authenticated-orcid":false,"given":"Shinji","family":"Matsumoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Kikuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,20]]},"reference":[{"key":"858_CR1","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.jhep.2017.12.018","volume":"68","author":"S Abitbol","year":"2018","unstructured":"Abitbol S, Dahmani R, Coulouarn C, Ragazzon B, Mlecnik B, Senni N, Savall M, Bossard P, Sohier P, Drouet V, Tournier E, Dumont F, Sanson R, Calderaro J, Zucman-Rossi J, Vasseur-Cognet M, Just PA, Terris B, Perret C, Gilgenkrantz H (2018) AXIN deficiency in human and mouse hepatocytes induces hepatocellular carcinoma in the absence of \u03b2-catenin activation. J Hepatol 68:1203\u20131213","journal-title":"J Hepatol"},{"key":"858_CR2","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.cmet.2019.01.002","volume":"29","author":"AO Adebayo Michael","year":"2019","unstructured":"Adebayo Michael AO, Ko S, Tao J, Moghe A, Yang H, Xu M, Russell JO, Pradhan-Sundd T, Liu S, Singh S, Poddar M, Monga JS, Liu P, Oertel M, Ranganathan S, Singhi A, Rebouissou S, Zucman-Rossi J, Ribback S, Calvisi D, Qvartskhava N, G\u00f6rg B, H\u00e4ussinger D, Chen X, Monga SP (2019) Inhibiting Glutamine-Dependent mTORC1 Activation Ameliorates Liver Cancers Driven by \u03b2-Catenin Mutations. Cell Metab 29:1135-1150.e1136","journal-title":"Cell Metab"},{"key":"858_CR3","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1002\/hep.21317","volume":"44","author":"U Apte","year":"2006","unstructured":"Apte U, Zeng G, Muller P, Tan X, Micsenyi A, Cieply B, Dai C, Liu Y, Kaestner KH, Monga SP (2006) Activation of Wnt\/\u03b2-catenin pathway during hepatocyte growth factor-induced hepatomegaly in mice. Hepatology 44:992\u20131002","journal-title":"Hepatology"},{"key":"858_CR4","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.biocel.2009.07.012","volume":"43","author":"C Armengol","year":"2011","unstructured":"Armengol C, Cairo S, Fabre M, Buendia MA (2011) Wnt signaling and hepatocarcinogenesis: the hepatoblastoma model. Int J Biochem Cell Biol 43:265\u2013270","journal-title":"Int J Biochem Cell Biol"},{"key":"858_CR5","doi-asserted-by":"crossref","first-page":"744","DOI":"10.2353\/ajpath.2010.090667","volume":"176","author":"J Behari","year":"2010","unstructured":"Behari J, Yeh TH, Krauland L, Otruba W, Cieply B, Hauth B, Apte U, Wu T, Evans R, Monga SP (2010) Liver-specific \u03b2-catenin knockout mice exhibit defective bile acid and cholesterol homeostasis and increased susceptibility to diet-induced steatohepatitis. Am J Pathol 176:744\u2013753","journal-title":"Am J Pathol"},{"key":"858_CR6","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/382638a0","volume":"382","author":"J Behrens","year":"1996","unstructured":"Behrens J, von Kries JP, K\u00fchl M, Bruhn L, Wedlich D, Grosschedl R, Birchmeier W (1996) Functional interaction of \u03b2-catenin with the transcription factor LEF-1. Nature 382:638\u2013642","journal-title":"Nature"},{"key":"858_CR7","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.devcel.2006.03.015","volume":"10","author":"S Benhamouche","year":"2006","unstructured":"Benhamouche S, Decaens T, Godard C, Chambrey R, Rickman DS, Moinard C, Vasseur-Cognet M, Kuo CJ, Kahn A, Perret C, Colnot S (2006) Apc tumor suppressor gene is the \u201czonation-keeper\u201d of mouse liver. Dev Cell 10:759\u2013770","journal-title":"Dev Cell"},{"key":"858_CR8","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41568-020-00307-z","volume":"21","author":"JM Bugter","year":"2021","unstructured":"Bugter JM, Fenderico N, Maurice MM (2021) Mutations and mechanisms of WNT pathway tumour suppressors in cancer. Nat Rev Cancer 21:5\u201321","journal-title":"Nat Rev Cancer"},{"key":"858_CR9","first-page":"3245","volume":"61","author":"A Cadoret","year":"2001","unstructured":"Cadoret A, Ovejero C, Saadi-Kheddouci S, Souil E, Fabre M, Romagnolo B, Kahn A, Perret C (2001) Hepatomegaly in transgenic mice expressing an oncogenic form of \u03b2-catenin. Cancer Res 61:3245\u20133249","journal-title":"Cancer Res"},{"key":"858_CR10","doi-asserted-by":"crossref","first-page":"8293","DOI":"10.1038\/sj.onc.1206118","volume":"21","author":"A Cadoret","year":"2002","unstructured":"Cadoret A, Ovejero C, Terris B, Souil E, L\u00e9vy L, Lamers WH, Kitajewski J, Kahn A, Perret C (2002) New targets of \u03b2-catenin signaling in the liver are involved in the glutamine metabolism. Oncogene 21:8293\u20138301","journal-title":"Oncogene"},{"key":"858_CR11","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.ccr.2008.11.002","volume":"14","author":"S Cairo","year":"2008","unstructured":"Cairo S, Armengol C, De Reyni\u00e8s A, Wei Y, Thomas E, Renard CA, Goga A, Balakrishnan A, Semeraro M, Gresh L, Pontoglio M, Strick-Marchand H, Levillayer F, Nouet Y, Rickman D, Gauthier F, Branchereau S, Brugi\u00e8res L, Laithier V, Bouvier R, Boman F, Basso G, Michiels JF, Hofman P, Arbez-Gindre F, Jouan H, Rousselet-Chapeau MC, Berrebi D, Marcellin L, Plenat F, Zachar D, Joubert M, Selves J, Pasquier D, Bioulac-Sage P, Grotzer M, Childs M, Fabre M, Buendia MA (2008) Hepatic stem-like phenotype and interplay of Wnt\/\u03b2-catenin and Myc signaling in aggressive childhood liver cancer. Cancer Cell 14:471\u2013484","journal-title":"Cancer Cell"},{"issue":"1327\u20131341","key":"858_CR12","first-page":"e1323","volume":"169","author":"Cancer Genome Atlas Research Network. Electronic address wbe, Cancer Genome Atlas Research N","year":"2017","unstructured":"Cancer Genome Atlas Research Network. Electronic address wbe, Cancer Genome Atlas Research N (2017) Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell 169(1327\u20131341):e1323","journal-title":"Cell"},{"key":"858_CR13","doi-asserted-by":"crossref","first-page":"G39","DOI":"10.1152\/ajpgi.00263.2007","volume":"294","author":"JH Cheng","year":"2008","unstructured":"Cheng JH, She H, Han YP, Wang J, Xiong S, Asahina K, Tsukamoto H (2008) Wnt antagonism inhibits hepatic stellate cell activation and liver fibrosis. Am J Physiol Gastrointest Liver Physiol 294:G39-49","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"858_CR14","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1038\/bjc.2014.425","volume":"111","author":"M Chiu","year":"2014","unstructured":"Chiu M, Tardito S, Pillozzi S, Arcangeli A, Armento A, Uggeri J, Missale G, Bianchi MG, Barilli A, Dall\u2019Asta V, Campanini N, Silini EM, Fuchs J, Armeanu-Ebinger S, Bussolati O (2014) Glutamine depletion by crisantaspase hinders the growth of human hepatocellular carcinoma xenografts. Br J Cancer 111:1159\u20131167","journal-title":"Br J Cancer"},{"key":"858_CR15","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.cell.2012.05.012","volume":"149","author":"H Clevers","year":"2012","unstructured":"Clevers H, Nusse R (2012) Wnt\/\u03b2-catenin signaling and disease. Cell 149:1192\u20131205","journal-title":"Cell"},{"key":"858_CR16","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1242\/dev.129.8.1819","volume":"129","author":"F Clotman","year":"2002","unstructured":"Clotman F, Lannoy VJ, Reber M, Cereghini S, Cassiman D, Jacquemin P, Roskams T, Rousseau GG, Lemaigre FP (2002) The onecut transcription factor HNF6 is required for normal development of the biliary tract. Development 129:1819\u20131828","journal-title":"Development"},{"key":"858_CR17","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1242\/dev.129.8.1829","volume":"129","author":"C Coffinier","year":"2002","unstructured":"Coffinier C, Gresh L, Fiette L, Tronche F, Sch\u00fctz G, Babinet C, Pontoglio M, Yaniv M, Barra J (2002) Bile system morphogenesis defects and liver dysfunction upon targeted deletion of HNF1\u03b2. Development 129:1829\u20131838","journal-title":"Development"},{"key":"858_CR18","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.diff.2016.02.001","volume":"91","author":"S Cordi","year":"2016","unstructured":"Cordi S, Godard C, Saandi T, Jacquemin P, Monga SP, Colnot S, Lemaigre FP (2016) Role of \u03b2-catenin in development of bile ducts. Differentiation 91:42\u201349","journal-title":"Differentiation"},{"key":"858_CR19","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/0959-437X(95)80024-7","volume":"5","author":"GJ Darlington","year":"1995","unstructured":"Darlington GJ, Wang N, Hanson RW (1995) C\/EBP\u03b1\u202f: a critical regulator of genes governing integrative metabolic processes. Curr Opin Genet Dev 5:565\u2013570","journal-title":"Curr Opin Genet Dev"},{"key":"858_CR20","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1101\/gad.235473.113","volume":"28","author":"W de Lau","year":"2014","unstructured":"de Lau W, Peng WC, Gros P, Clevers H (2014) The R-spondin\/Lgr5\/Rnf43 module: regulator of Wnt signal strength. Genes Dev 28:305\u2013316","journal-title":"Genes Dev"},{"key":"858_CR21","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/hep.21952","volume":"47","author":"T Decaens","year":"2008","unstructured":"Decaens T, Godard C, de Reyni\u00e8s A, Rickman DS, Tronche F, Couty JP, Perret C, Colnot S (2008) Stabilization of \u03b2-catenin affects mouse embryonic liver growth and hepatoblast fate. Hepatology 47:247\u2013258","journal-title":"Hepatology"},{"key":"858_CR22","doi-asserted-by":"crossref","first-page":"867","DOI":"10.2174\/15680096113139990081","volume":"13","author":"E Delgado","year":"2013","unstructured":"Delgado E, Bahal R, Yang J, Lee JM, Ly DH, Monga SP (2013) \u03b2-Catenin knockdown in liver tumor cells by a cell permeable gamma guanidine-based peptide nucleic acid. Curr Cancer Drug Targets 13:867\u2013878","journal-title":"Curr Cancer Drug Targets"},{"key":"858_CR23","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jhep.2014.10.021","volume":"62","author":"E Delgado","year":"2015","unstructured":"Delgado E, Okabe H, Preziosi M, Russell JO, Alvarado TF, Oertel M, Nejak-Bowen KN, Zhang Y, Monga SP (2015) Complete response of Ctnnb1-mutated tumours to \u03b2-catenin suppression by locked nucleic acid antisense in a mouse hepatocarcinogenesis model. J Hepatol 62:380\u2013387","journal-title":"J Hepatol"},{"key":"858_CR24","doi-asserted-by":"crossref","first-page":"e95307","DOI":"10.1371\/journal.pone.0095307","volume":"9","author":"X Ding","year":"2014","unstructured":"Ding X, Yang Y, Han B, Du C, Xu N, Huang H, Cai T, Zhang A, Han ZG, Zhou W, Chen L (2014) Transcriptomic characterization of hepatocellular carcinoma with CTNNB1 mutation. PLoS ONE 9:e95307","journal-title":"PLoS ONE"},{"key":"858_CR25","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.jhep.2014.08.009","volume":"61","author":"M Eichenm\u00fcller","year":"2014","unstructured":"Eichenm\u00fcller M, Trippel F, Kreuder M, Beck A, Schwarzmayr T, H\u00e4berle B, Cairo S, Leuschner I, von Schweinitz D, Strom TM, Kappler R (2014) The genomic landscape of hepatoblastoma and their progenies with HCC-like features. J Hepatol 61:1312\u20131320","journal-title":"J Hepatol"},{"key":"858_CR26","doi-asserted-by":"crossref","first-page":"12682","DOI":"10.1073\/pnas.0404875101","volume":"101","author":"KH Emami","year":"2004","unstructured":"Emami KH, Nguyen C, Ma H, Kim DH, Jeong KW, Eguchi M, Moon RT, Teo JL, Kim HY, Moon SH, Ha JR, Kahn M (2004) A small molecule inhibitor of \u03b2-catenin\/CREB-binding protein transcription [corrected]. Proc Natl Acad Sci USA 101:12682\u201312687","journal-title":"Proc Natl Acad Sci USA"},{"key":"858_CR27","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1056\/NEJMoa1915745","volume":"382","author":"RS Finn","year":"2020","unstructured":"Finn RS, Qin S, Ikeda M, Galle PR, Ducreux M, Kim TY, Kudo M, Breder V, Merle P, Kaseb AO, Li D, Verret W, Xu DZ, Hernandez S, Liu J, Huang C, Mulla S, Wang Y, Lim HY, Zhu AX, Cheng AL (2020) Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma. N Engl J Med 382:1894\u20131905","journal-title":"N Engl J Med"},{"key":"858_CR28","doi-asserted-by":"crossref","first-page":"D777","DOI":"10.1093\/nar\/gkw1121","volume":"45","author":"SA Forbes","year":"2017","unstructured":"Forbes SA, Beare D, Boutselakis H, Bamford S, Bindal N, Tate J, Cole CG, Ward S, Dawson E, Ponting L, Stefancsik R, Harsha B, Kok CY, Jia M, Jubb H, Sondka Z, Thompson S, De T, Campbell PJ (2017) COSMIC: somatic cancer genetics at high-resolution. Nucleic Acids Res 45:D777-d783","journal-title":"Nucleic Acids Res"},{"key":"858_CR29","doi-asserted-by":"crossref","first-page":"R52","DOI":"10.1186\/gb-2012-13-9-r52","volume":"13","author":"S Frietze","year":"2012","unstructured":"Frietze S, Wang R, Yao L, Tak YG, Ye Z, Gaddis M, Witt H, Farnham PJ, Jin VX (2012) Cell type-specific binding patterns reveal that TCF7L2 can be tethered to the genome by association with GATA3. Genome Biol 13:R52","journal-title":"Genome Biol"},{"key":"858_CR30","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1186\/s13046-019-1396-4","volume":"38","author":"Y Fu","year":"2019","unstructured":"Fu Y, Liu S, Zeng S, Shen H (2019) From bench to bed: the tumor immune microenvironment and current immunotherapeutic strategies for hepatocellular carcinoma. J Exp Clin Cancer Res 38:396","journal-title":"J Exp Clin Cancer Res"},{"key":"858_CR31","doi-asserted-by":"crossref","first-page":"4834","DOI":"10.1038\/onc.2014.402","volume":"34","author":"S Fujii","year":"2015","unstructured":"Fujii S, Matsumoto S, Nojima S, Morii E, Kikuchi A (2015) Arl4c expression in colorectal and lung cancers promotes tumorigenesis and may represent a novel therapeutic target. Oncogene 34:4834\u20134844","journal-title":"Oncogene"},{"key":"858_CR32","doi-asserted-by":"crossref","first-page":"81571","DOI":"10.18632\/oncotarget.13147","volume":"7","author":"S Fujii","year":"2016","unstructured":"Fujii S, Shinjo K, Matsumoto S, Harada T, Nojima S, Sato S, Usami Y, Toyosawa S, Morii E, Kondo Y, Kikuchi A (2016) Epigenetic upregulation of ARL4C, due to DNA hypomethylation in the 3\u2032-untranslated region, promotes tumorigenesis of lung squamous cell carcinoma. Oncotarget 7:81571\u201381587","journal-title":"Oncotarget"},{"key":"858_CR33","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1158\/1535-7163.MCT-16-0309","volume":"15","author":"S Ganesh","year":"2016","unstructured":"Ganesh S, Koser ML, Cyr WA, Chopda GR, Tao J, Shui X, Ying B, Chen D, Pandya P, Chipumuro E, Siddiquee Z, Craig K, Lai C, Dudek H, Monga SP, Wang W, Brown BD, Abrams MT (2016) Direct pharmacological inhibition of \u03b2-catenin by RNA interference in tumors of diverse origin. Mol Cancer Ther 15:2143\u20132154","journal-title":"Mol Cancer Ther"},{"key":"858_CR34","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.3892\/mmr.2014.2099","volume":"9","author":"WS Ge","year":"2014","unstructured":"Ge WS, Wang YJ, Wu JX, Fan JG, Chen YW, Zhu L (2014) \u03b2-catenin is overexpressed in hepatic fibrosis and blockage of Wnt\/\u03b2-catenin signaling inhibits hepatic stellate cell activation. Mol Med Rep 9:2145\u20132151","journal-title":"Mol Med Rep"},{"key":"858_CR35","first-page":"6367","volume":"60","author":"MG Ghosh","year":"2000","unstructured":"Ghosh MG, Thompson DA, Weigel RJ (2000) PDZK1 and GREB1 are estrogen-regulated genes expressed in hormone-responsive breast cancer. Cancer Res 60:6367\u20136375","journal-title":"Cancer Res"},{"key":"858_CR36","doi-asserted-by":"crossref","first-page":"4317","DOI":"10.1200\/JCO.20.02672","volume":"38","author":"JD Gordan","year":"2020","unstructured":"Gordan JD, Kennedy EB, Abou-Alfa GK, Beg MS, Brower ST, Gade TP, Goff L, Gupta S, Guy J, Harris WP, Iyer R, Jaiyesimi I, Jhawer M, Karippot A, Kaseb AO, Kelley RK, Knox JJ, Kortmansky J, Leaf A, Remak WM, Shroff RT, Sohal DPS, Taddei TH, Venepalli NK, Wilson A, Zhu AX, Rose MG (2020) Systemic therapy for advanced hepatocellular carcinoma: ASCO guideline. J Clin Oncol 38:4317\u20134345","journal-title":"J Clin Oncol"},{"key":"858_CR37","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1002\/hep.26924","volume":"59","author":"A Gougelet","year":"2014","unstructured":"Gougelet A, Torre C, Veber P, Sartor C, Bachelot L, Denechaud PD, Godard C, Moldes M, Burnol AF, Dubuquoy C, Terris B, Guillonneau F, Ye T, Schwarz M, Braeuning A, Perret C, Colnot S (2014) T-cell factor 4 and \u03b2-catenin chromatin occupancies pattern zonal liver metabolism in mice. Hepatology 59:2344\u20132357","journal-title":"Hepatology"},{"key":"858_CR38","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/nature11019","volume":"485","author":"HX Hao","year":"2012","unstructured":"Hao HX, Xie Y, Zhang Y, Charlat O, Oster E, Avello M, Lei H, Mickanin C, Liu D, Ruffner H, Mao X, Ma Q, Zamponi R, Bouwmeester T, Finan PM, Kirschner MW, Porter JA, Serluca FC, Cong F (2012) ZNRF3 promotes Wnt receptor turnover in an R-spondin-sensitive manner. Nature 485:195\u2013200","journal-title":"Nature"},{"key":"858_CR39","doi-asserted-by":"crossref","first-page":"e66721","DOI":"10.7554\/eLife.66721","volume":"10","author":"A Harada","year":"2021","unstructured":"Harada A, Matsumoto S, Yasumizu Y, Shojima K, Akama T, Eguchi H, Kikuchi A (2021) Localization of KRAS downstream target ARL4C to invasive pseudopods accelerates pancreatic cancer cell invasion. eLife 10:e66721","journal-title":"eLife"},{"key":"858_CR40","first-page":"1971","volume":"62","author":"N Harada","year":"2002","unstructured":"Harada N, Miyoshi H, Murai N, Oshima H, Tamai Y, Oshima M, Taketo MM (2002) Lack of tumorigenesis in the mouse liver after adenovirus-mediated expression of a dominant stable mutant of \u03b2-catenin. Cancer Res 62:1971\u20131977","journal-title":"Cancer Res"},{"key":"858_CR41","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1158\/1535-7163.MCT-18-0824","volume":"18","author":"T Harada","year":"2019","unstructured":"Harada T, Matsumoto S, Hirota S, Kimura H, Fujii S, Kasahara Y, Gon H, Yoshida T, Itoh T, Haraguchi N, Mizushima T, Noda T, Eguchi H, Nojima S, Morii E, Fukumoto T, Obika S, Kikuchi A (2019) Chemically modified antisense oligonucleotide against ARL4C inhibits primary and metastatic liver tumor growth. Mol Cancer Ther 18:602\u2013612","journal-title":"Mol Cancer Ther"},{"key":"858_CR42","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1158\/1078-0432.CCR-18-2293","volume":"25","author":"JJ Harding","year":"2019","unstructured":"Harding JJ, Nandakumar S, Armenia J, Khalil DN, Albano M, Ly M, Shia J, Hechtman JF, Kundra R, El Dika I, Do RK, Sun Y, Kingham TP, D\u2019Angelica MI, Berger MF, Hyman DM, Jarnagin W, Klimstra DS, Janjigian YY, Solit DB, Schultz N, Abou-Alfa GK (2019) Prospective genotyping of hepatocellular carcinoma: clinical implications of next-generation sequencing for matching patients to targeted and immune therapies. Clin Cancer Res 25:2116\u20132126","journal-title":"Clin Cancer Res"},{"key":"858_CR43","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/18899","volume":"398","author":"JC Hsieh","year":"1999","unstructured":"Hsieh JC, Kodjabachian L, Rebbert ML, Rattner A, Smallwood PM, Samos CH, Nusse R, Dawid IB, Nathans J (1999) A new secreted protein that binds to Wnt proteins and inhibits their activities. Nature 398:431\u2013436","journal-title":"Nature"},{"key":"858_CR44","doi-asserted-by":"crossref","first-page":"100754","DOI":"10.1016\/j.xcrm.2022.100754","volume":"3","author":"S Hu","year":"2022","unstructured":"Hu S, Liu S, Bian Y, Poddar M, Singh S, Cao C, McGaughey J, Bell A, Blazer LL, Adams JJ, Sidhu SS, Angers S, Monga SP (2022) Single-cell spatial transcriptomics reveals a dynamic control of metabolic zonation and liver regeneration by endothelial cell Wnt2 and Wnt9b. Cell Rep Med 3:100754","journal-title":"Cell Rep Med"},{"key":"858_CR45","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1016\/S0002-9440(10)65496-X","volume":"155","author":"H Huang","year":"1999","unstructured":"Huang H, Fujii H, Sankila A, Mahler-Araujo BM, Matsuda M, Cathomas G, Ohgaki H (1999) \u03b2-catenin mutations are frequent in human hepatocellular carcinomas associated with hepatitis C virus infection. Am J Pathol 155:1795\u20131801","journal-title":"Am J Pathol"},{"key":"858_CR46","doi-asserted-by":"crossref","unstructured":"Iwafuchi-Doi M, Donahue G, Kakumanu A, Watts JA, Mahony S, Pugh BF, Lee D, Kaestner KH, Zaret KS (2016) The pioneer transcription factor FoxA maintains an accessible nucleosome configuration at enhancers for tissue-specific gene activation. Mol Cell 62:79\u201391","DOI":"10.1016\/j.molcel.2016.03.001"},{"key":"858_CR47","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13027-020-00297-5","volume":"15","author":"D Javanmard","year":"2020","unstructured":"Javanmard D, Najafi M, Babaei MR, Karbalaie Niya MH, Esghaei M, Panahi M, Safarnezhad Tameshkel F, Tavakoli A, Jazayeri SM, Ghaffari H, Ataei-Pirkooh A, Monavari SH, Bokharaei-Salim F (2020) Investigation of CTNNB1 gene mutations and expression in hepatocellular carcinoma and cirrhosis in association with hepatitis B virus infection. Infect Agent Cancer 15:37","journal-title":"Infect Agent Cancer"},{"key":"858_CR48","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1152\/physrev.1989.69.3.708","volume":"69","author":"K Jungermann","year":"1989","unstructured":"Jungermann K, Katz N (1989) Functional specialization of different hepatocyte populations. Physiol Rev 69:708\u2013764","journal-title":"Physiol Rev"},{"key":"858_CR49","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/nrd4233","volume":"13","author":"M Kahn","year":"2014","unstructured":"Kahn M (2014) Can we safely target the WNT pathway? Nat Rev Drug Discov 13:513\u2013532","journal-title":"Nat Rev Drug Discov"},{"key":"858_CR50","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.molmed.2023.03.006","volume":"29","author":"VL Katanaev","year":"2023","unstructured":"Katanaev VL, Baldin A, Denisenko TV, Silachev DN, Ivanova AE, Sukhikh GT, Jia L, Ashrafyan LA (2023) Cells of the tumor microenvironment speak the Wnt language. Trends Mol Med 29:468\u2013480","journal-title":"Trends Mol Med"},{"key":"858_CR51","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1242\/jcs.00623","volume":"116","author":"Y Kawano","year":"2003","unstructured":"Kawano Y, Kypta R (2003) Secreted antagonists of the Wnt signalling pathway. J Cell Sci 116:2627\u20132634","journal-title":"J Cell Sci"},{"key":"858_CR52","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1093\/aje\/kwx322","volume":"187","author":"RD Kehm","year":"2018","unstructured":"Kehm RD, Spector LG, Poynter JN, Vock DM, Osypuk TL (2018) Socioeconomic status and childhood cancer incidence: a population-based multilevel analysis. Am J Epidemiol 187:982\u2013991","journal-title":"Am J Epidemiol"},{"key":"858_CR53","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.tcb.2009.01.003","volume":"19","author":"A Kikuchi","year":"2009","unstructured":"Kikuchi A, Yamamoto H, Sato A (2009) Selective activation mechanisms of Wnt signaling pathways. Trends Cell Biol 19:119\u2013129","journal-title":"Trends Cell Biol"},{"key":"858_CR54","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/B978-0-12-386035-4.00002-1","volume":"291","author":"A Kikuchi","year":"2011","unstructured":"Kikuchi A, Yamamoto H, Sato A, Matsumoto S (2011) New insights into the mechanism of Wnt signaling pathway activation. Int Rev Cell Mol Biol 291:21\u201371","journal-title":"Int Rev Cell Mol Biol"},{"key":"858_CR55","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.jhep.2007.12.020","volume":"48","author":"M Kim","year":"2008","unstructured":"Kim M, Lee HC, Tsedensodnom O, Hartley R, Lim YS, Yu E, Merle P, Wands JR (2008) Functional interaction between Wnt3 and Frizzled-7 leads to activation of the Wnt\/\u03b2-catenin signaling pathway in hepatocellular carcinoma cells. J Hepatol 48:780\u2013791","journal-title":"J Hepatol"},{"key":"858_CR56","doi-asserted-by":"publisher","DOI":"10.1111\/cas.14303","author":"K Kimura","year":"2020","unstructured":"Kimura K, Matsumoto S, Harada T, Morii E, Nagatomo I, Shintani Y, Kikuchi A (2020) ARL4C is associated with initiation and progression of lung adenocarcinoma and represents a therapeutic target. Cancer Sci 111:951-961","journal-title":"Cancer Sci"},{"key":"858_CR57","doi-asserted-by":"crossref","first-page":"483","DOI":"10.3389\/fimmu.2018.00483","volume":"9","author":"JC Kling","year":"2018","unstructured":"Kling JC, Jordan MA, Pitt LA, Meiners J, Thanh-Tran T, Tran LS, Nguyen TTK, Mittal D, Villani R, Steptoe RJ, Khosrotehrani K, Berzins SP, Baxter AG, Godfrey DI, Blumenthal A (2018) Temporal regulation of natural killer T cell interferon gamma responses by \u03b2-catenin-dependent and -independent Wnt signaling. Front Immunol 9:483","journal-title":"Front Immunol"},{"key":"858_CR58","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1083\/jcb.130.1.67","volume":"130","author":"KA Knudsen","year":"1995","unstructured":"Knudsen KA, Soler AP, Johnson KR, Wheelock MJ (1995) Interaction of alpha-actinin with the cadherin\/catenin cell-cell adhesion complex via alpha-catenin. J Cell Biol 130:67\u201377","journal-title":"J Cell Biol"},{"key":"858_CR59","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/nature11308","volume":"488","author":"BK Koo","year":"2012","unstructured":"Koo BK, Spit M, Jordens I, Low TY, Stange DE, van de Wetering M, van Es JH, Mohammed S, Heck AJ, Maurice MM, Clevers H (2012) Tumour suppressor RNF43 is a stem-cell E3 ligase that induces endocytosis of Wnt receptors. Nature 488:665\u2013669","journal-title":"Nature"},{"key":"858_CR60","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ctrv.2017.11.002","volume":"62","author":"N Krishnamurthy","year":"2018","unstructured":"Krishnamurthy N, Kurzrock R (2018) Targeting the Wnt\/\u03b2-catenin pathway in cancer: update on effectors and inhibitors. Cancer Treat Rev 62:50\u201360","journal-title":"Cancer Treat Rev"},{"key":"858_CR61","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.tcb.2016.05.011","volume":"26","author":"PF Langton","year":"2016","unstructured":"Langton PF, Kakugawa S, Vincent JP (2016) Making, exporting, and modulating Wnts. Trends Cell Biol 26:756\u2013765","journal-title":"Trends Cell Biol"},{"key":"858_CR62","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/hep.29613","volume":"68","author":"T Leibing","year":"2018","unstructured":"Leibing T, G\u00e9raud C, Augustin I, Boutros M, Augustin HG, Okun JG, Langhans CD, Zierow J, Wohlfeil SA, Olsavszky V, Schledzewski K, Goerdt S, Koch PS (2018) Angiocrine Wnt signaling controls liver growth and metabolic maturation in mice. Hepatology 68:707\u2013722","journal-title":"Hepatology"},{"key":"858_CR63","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1111\/cas.12471","volume":"105","author":"HJ Lenz","year":"2014","unstructured":"Lenz HJ, Kahn M (2014) Safely targeting cancer stem cells via selective catenin coactivator antagonism. Cancer Sci 105:1087\u20131092","journal-title":"Cancer Sci"},{"key":"858_CR64","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1053\/j.gastro.2019.11.302","volume":"158","author":"P Liu","year":"2020","unstructured":"Liu P, Liang B, Liu M, Lebbink JHG, Li S, Qian M, Lavrijsen M, Peppelenbosch MP, Chen X, Smits R (2020) Oncogenic mutations in armadillo repeats 5 and 6 of \u03b2-catenin reduce binding to APC, increasing signaling and transcription of target genes. Gastroenterology 158:1029-1043.e1010","journal-title":"Gastroenterology"},{"key":"858_CR65","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.canlet.2018.11.030","volume":"443","author":"R Liu","year":"2019","unstructured":"Liu R, Li Y, Tian L, Shi H, Wang J, Liang Y, Sun B, Wang S, Zhou M, Wu L, Nie J, Lin B, Tang S, Zhang Y, Wang G, Zhang C, Han J, Xu B, Liu L, Gong K, Zheng T (2019) Gankyrin drives metabolic reprogramming to promote tumorigenesis, metastasis and drug resistance through activating \u03b2-catenin\/c-Myc signaling in human hepatocellular carcinoma. Cancer Lett 443:34\u201346","journal-title":"Cancer Lett"},{"key":"858_CR66","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","volume":"7","author":"JM Llovet","year":"2021","unstructured":"Llovet JM, Kelley RK, Villanueva A, Singal AG, Pikarsky E, Roayaie S, Lencioni R, Koike K, Zucman-Rossi J, Finn RS (2021) Hepatocellular carcinoma. Nat Rev Dis Primers 7:6","journal-title":"Nat Rev Dis Primers"},{"key":"858_CR67","doi-asserted-by":"crossref","first-page":"5753","DOI":"10.1242\/dev.01411","volume":"131","author":"K Lorent","year":"2004","unstructured":"Lorent K, Yeo SY, Oda T, Chandrasekharappa S, Chitnis A, Matthews RP, Pack M (2004) Inhibition of Jagged-mediated Notch signaling disrupts zebrafish biliary development and generates multi-organ defects compatible with an Alagille syndrome phenocopy. Development 131:5753\u20135766","journal-title":"Development"},{"key":"858_CR68","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s12943-019-1047-6","volume":"18","author":"C Lu","year":"2019","unstructured":"Lu C, Rong D, Zhang B, Zheng W, Wang X, Chen Z, Tang W (2019) Current perspectives on the immunosuppressive tumor microenvironment in hepatocellular carcinoma: challenges and opportunities. Mol Cancer 18:130","journal-title":"Mol Cancer"},{"key":"858_CR69","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1159\/000362821","volume":"87","author":"LC Lu","year":"2014","unstructured":"Lu LC, Shao YY, Lee YH, Hsieh MS, Hsiao CH, Lin HH, Kao HF, Ma YY, Yen FC, Cheng AL, Hsu CH (2014) \u03b2-catenin (CTNNB1) mutations are not associated with prognosis in advanced hepatocellular carcinoma. Oncology 87:159\u2013166","journal-title":"Oncology"},{"key":"858_CR70","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.devcel.2009.06.016","volume":"17","author":"BT MacDonald","year":"2009","unstructured":"MacDonald BT, Tamai K, He X (2009) Wnt\/\u03b2-catenin signaling: components, mechanisms, and diseases. Dev Cell 17:9\u201326","journal-title":"Dev Cell"},{"key":"858_CR71","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1002\/embj.201386942","volume":"33","author":"S Matsumoto","year":"2014","unstructured":"Matsumoto S, Fujii S, Sato A, Ibuka S, Kagawa Y, Ishii M, Kikuchi A (2014) A combination of Wnt and growth factor signaling induces Arl4c expression to form epithelial tubular structures. EMBO J 33:702\u2013718","journal-title":"EMBO J"},{"key":"858_CR72","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1158\/0008-5472.CAN-22-3518","volume":"83","author":"S Matsumoto","year":"2023","unstructured":"Matsumoto S, Harada A, Seta M, Akita M, Gon H, Fukumoto T, Kikuchi A (2023) Wnt signaling stimulates cooperation between GREB1 and HNF4\u03b1 to promote proliferation in hepatocellular carcinoma. Cancer Res 83:2312\u20132327","journal-title":"Cancer Res"},{"key":"858_CR73","doi-asserted-by":"crossref","first-page":"3882","DOI":"10.1038\/s41467-019-11533-x","volume":"10","author":"S Matsumoto","year":"2019","unstructured":"Matsumoto S, Yamamichi T, Shinzawa K, Kasahara Y, Nojima S, Kodama T, Obika S, Takehara T, Morii E, Okuyama H, Kikuchi A (2019) GREB1 induced by Wnt signaling promotes development of hepatoblastoma by suppressing TGF\u03b2 signaling. Nat Commun 10:3882","journal-title":"Nat Commun"},{"key":"858_CR74","doi-asserted-by":"crossref","unstructured":"Mavila N, Thundimadathil J (2019) The emerging roles of cancer stem cells and Wnt\/beta-catenin signaling in hepatoblastoma. Cancers (Basel) 11:1406","DOI":"10.3390\/cancers11101406"},{"key":"858_CR75","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1053\/j.gastro.2004.07.009","volume":"127","author":"P Merle","year":"2004","unstructured":"Merle P, de la Monte S, Kim M, Herrmann M, Tanaka S, Von Dem Bussche A, Kew MC, Trepo C, Wands JR (2004) Functional consequences of frizzled-7 receptor overexpression in human hepatocellular carcinoma. Gastroenterology 127:1110\u20131122","journal-title":"Gastroenterology"},{"key":"858_CR76","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41575-020-0342-4","volume":"18","author":"GK Michalopoulos","year":"2021","unstructured":"Michalopoulos GK, Bhushan B (2021) Liver regeneration: biological and pathological mechanisms and implications. Nat Rev Gastroenterol Hepatol 18:40\u201355","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"858_CR77","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.celrep.2013.01.010","volume":"3","author":"H Mohammed","year":"2013","unstructured":"Mohammed H, D\u2019Santos C, Serandour AA, Ali HR, Brown GD, Atkins A, Rueda OM, Holmes KA, Theodorou V, Robinson JL, Zwart W, Saadi A, Ross-Innes CS, Chin SF, Menon S, Stingl J, Palmieri C, Caldas C, Carroll JS (2013) Endogenous purification reveals GREB1 as a key estrogen receptor regulatory factor. Cell Rep 3:342\u2013349","journal-title":"Cell Rep"},{"key":"858_CR78","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1053\/j.gastro.2015.02.056","volume":"148","author":"SP Monga","year":"2015","unstructured":"Monga SP (2015) \u03b2-Catenin signaling and roles in liver homeostasis, injury, and tumorigenesis. Gastroenterology 148:1294\u20131310","journal-title":"Gastroenterology"},{"key":"858_CR79","first-page":"2064","volume":"62","author":"SP Monga","year":"2002","unstructured":"Monga SP, Mars WM, Pediaditakis P, Bell A, Mul\u00e9 K, Bowen WC, Wang X, Zarnegar R, Michalopoulos GK (2002) Hepatocyte growth factor induces Wnt-independent nuclear translocation of \u03b2-catenin after Met-\u03b2-catenin dissociation in hepatocytes. Cancer Res 62:2064\u20132071","journal-title":"Cancer Res"},{"key":"858_CR80","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1053\/jhep.2001.23786","volume":"33","author":"SP Monga","year":"2001","unstructured":"Monga SP, Pediaditakis P, Mule K, Stolz DB, Michalopoulos GK (2001) Changes in WNT\/\u03b2-catenin pathway during regulated growth in rat liver regeneration. Hepatology 33:1098\u20131109","journal-title":"Hepatology"},{"key":"858_CR81","doi-asserted-by":"crossref","first-page":"5423","DOI":"10.1038\/s41467-021-25430-9","volume":"12","author":"G Nagae","year":"2021","unstructured":"Nagae G, Yamamoto S, Fujita M, Fujita T, Nonaka A, Umeda T, Fukuda S, Tatsuno K, Maejima K, Hayashi A, Kurihara S, Kojima M, Hishiki T, Watanabe K, Ida K, Yano M, Hiyama Y, Tanaka Y, Inoue T, Ueda H, Nakagawa H, Aburatani H, Hiyama E (2021) Genetic and epigenetic basis of hepatoblastoma diversity. Nat Commun 12:5423","journal-title":"Nat Commun"},{"key":"858_CR82","first-page":"8564","volume":"61","author":"CJ Nelsen","year":"2001","unstructured":"Nelsen CJ, Rickheim DG, Timchenko NA, Stanley MW, Albrecht JH (2001) Transient expression of cyclin D1 is sufficient to promote hepatocyte replication and liver growth in vivo. Cancer Res 61:8564\u20138568","journal-title":"Cancer Res"},{"key":"858_CR83","doi-asserted-by":"crossref","first-page":"7469","DOI":"10.1038\/sj.onc.1210054","volume":"25","author":"C Niehrs","year":"2006","unstructured":"Niehrs C (2006) Function and biological roles of the Dickkopf family of Wnt modulators. Oncogene 25:7469\u20137481","journal-title":"Oncogene"},{"issue":"Pt 8","key":"858_CR84","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1242\/jcs.110.8.1013","volume":"110","author":"JE Nieset","year":"1997","unstructured":"Nieset JE, Redfield AR, Jin F, Knudsen KA, Johnson KR, Wheelock MJ (1997) Characterization of the interactions of \u03b1-catenin with \u03b1-actinin and \u03b2-catenin\/plakoglobin. J Cell Sci 110(Pt 8):1013\u20131022","journal-title":"J Cell Sci"},{"key":"858_CR85","doi-asserted-by":"crossref","first-page":"7640","DOI":"10.1158\/0008-5472.CAN-10-0824","volume":"70","author":"BF Ning","year":"2010","unstructured":"Ning BF, Ding J, Yin C, Zhong W, Wu K, Zeng X, Yang W, Chen YX, Zhang JP, Zhang X, Wang HY, Xie WF (2010) Hepatocyte nuclear factor 4 \u03b1 suppresses the development of hepatocellular carcinoma. Cancer Res 70:7640\u20137651","journal-title":"Cancer Res"},{"key":"858_CR86","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.cell.2017.05.016","volume":"169","author":"R Nusse","year":"2017","unstructured":"Nusse R, Clevers H (2017) Wnt\/\u03b2-catenin signaling, disease, and emerging therapeutic modalities. Cell 169:985\u2013999","journal-title":"Cell"},{"key":"858_CR87","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1002\/hep.32408","volume":"76","author":"J Paris","year":"2022","unstructured":"Paris J, Henderson NC (2022) Liver zonation, revisited. Hepatology 76:1219\u20131230","journal-title":"Hepatology"},{"key":"858_CR88","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/ng1175","volume":"34","author":"F Parviz","year":"2003","unstructured":"Parviz F, Matullo C, Garrison WD, Savatski L, Adamson JW, Ning G, Kaestner KH, Rossi JM, Zaret KS, Duncan SA (2003) Hepatocyte nuclear factor 4\u03b1 controls the development of a hepatic epithelium and liver morphogenesis. Nat Genet 34:292\u2013296","journal-title":"Nat Genet"},{"key":"858_CR89","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1158\/0008-5472.CAN-08-2514","volume":"69","author":"MA Patil","year":"2009","unstructured":"Patil MA, Lee SA, Macias E, Lam ET, Xu C, Jones KD, Ho C, Rodriguez-Puebla M, Chen X (2009) Role of cyclin D1 as a mediator of c-Met- and \u03b2-catenin-induced hepatocarcinogenesis. Cancer Res 69:253\u2013261","journal-title":"Cancer Res"},{"key":"858_CR90","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1126\/science.287.5458.1606","volume":"287","author":"M Peifer","year":"2000","unstructured":"Peifer M, Polakis P (2000) Wnt signaling in oncogenesis and embryogenesis\u2013a look outside the nucleus. Science 287:1606\u20131609","journal-title":"Science"},{"key":"858_CR91","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/s41575-018-0075-9","volume":"16","author":"MJ Perugorria","year":"2019","unstructured":"Perugorria MJ, Olaizola P, Labiano I, Esparza-Baquer A, Marzioni M, Marin JJG, Bujanda L, Banales JM (2019) Wnt-\u03b2-catenin signalling in liver development, health and disease. Nat Rev Gastroenterol Hepatol 16:121\u2013136","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"858_CR92","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.jhep.2013.07.001","volume":"59","author":"F Pez","year":"2013","unstructured":"Pez F, Lopez A, Kim M, Wands JR, Caron de Fromentel C, Merle P (2013) Wnt signaling and hepatocarcinogenesis: molecular targets for the development of innovative anticancer drugs. J Hepatol 59:1107\u20131117","journal-title":"J Hepatol"},{"key":"858_CR93","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1158\/1078-0432.CCR-18-3778","volume":"25","author":"R Pinyol","year":"2019","unstructured":"Pinyol R, Sia D, Llovet JM (2019) Immune exclusion-Wnt\/CTNNB1 class predicts resistance to immunotherapies in HCC. Clin Cancer Res 25:2021\u20132023","journal-title":"Clin Cancer Res"},{"key":"858_CR94","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/ncb3337","volume":"18","author":"L Planas-Paz","year":"2016","unstructured":"Planas-Paz L, Orsini V, Boulter L, Calabrese D, Pikiolek M, Nigsch F, Xie Y, Roma G, Donovan A, Marti P, Beckmann N, Dill MT, Carbone W, Bergling S, Isken A, Mueller M, Kinzel B, Yang Y, Mao X, Nicholson TB, Zamponi R, Capodieci P, Valdez R, Rivera D, Loew A, Ukomadu C, Terracciano LM, Bouwmeester T, Cong F, Heim MH, Forbes SJ, Ruffner H, Tchorz JS (2016) The RSPO-LGR4\/5-ZNRF3\/RNF43 module controls liver zonation and size. Nat Cell Biol 18:467\u2013479","journal-title":"Nat Cell Biol"},{"key":"858_CR95","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1002\/hep4.1196","volume":"2","author":"M Preziosi","year":"2018","unstructured":"Preziosi M, Okabe H, Poddar M, Singh S, Monga SP (2018) Endothelial Wnts regulate \u03b2-catenin signaling in murine liver zonation and regeneration: a sequel to the Wnt-Wnt situation. Hepatol Commun 2:845\u2013860","journal-title":"Hepatol Commun"},{"key":"858_CR96","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/1756-9966-30-96","volume":"30","author":"R Purcell","year":"2011","unstructured":"Purcell R, Childs M, Maibach R, Miles C, Turner C, Zimmermann A, Sullivan M (2011) HGF\/c-Met related activation of \u03b2-catenin in hepatoblastoma. J Exp Clin Cancer Res 30:96","journal-title":"J Exp Clin Cancer Res"},{"key":"858_CR97","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1002\/hep.30556","volume":"70","author":"Y Qiao","year":"2019","unstructured":"Qiao Y, Wang J, Karagoz E, Liang B, Song X, Shang R, Evert K, Xu M, Che L, Evert M, Calvisi DF, Tao J, Wang B, Monga SP, Chen X (2019) Axis inhibition protein 1 (Axin1) deletion-induced hepatocarcinogenesis requires intact \u03b2-catenin but not Notch cascade in mice. Hepatology 70:2003\u20132017","journal-title":"Hepatology"},{"key":"858_CR98","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s10549-005-1483-4","volume":"92","author":"JM Rae","year":"2005","unstructured":"Rae JM, Johnson MD, Scheys JO, Cordero KE, Larios JM, Lippman ME (2005) GREB 1 is a critical regulator of hormone dependent breast cancer growth. Breast Cancer Res Treat 92:141\u2013149","journal-title":"Breast Cancer Res Treat"},{"key":"858_CR99","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1053\/j.gastro.2020.06.010","volume":"159","author":"MNB Ramli","year":"2020","unstructured":"Ramli MNB, Lim YS, Koe CT, Demircioglu D, Tng W, Gonzales KAU, Tan CP, Szczerbinska I, Liang H, Soe EL, Lu Z, Ariyachet C, Yu KM, Koh SH, Yaw LP, Jumat NHB, Lim JSY, Wright G, Shabbir A, Dan YY, Ng HH, Chan YS (2020) Human pluripotent stem cell-derived organoids as models of liver disease. Gastroenterology 159:1471\u20131486.e1412","journal-title":"Gastroenterology"},{"key":"858_CR100","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jhep.2019.08.017","volume":"72","author":"S Rebouissou","year":"2020","unstructured":"Rebouissou S, Nault JC (2020) Advances in molecular classification and precision oncology in hepatocellular carcinoma. J Hepatol 72:215\u2013229","journal-title":"J Hepatol"},{"key":"858_CR101","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1146\/annurev-biochem-040320-103615","volume":"91","author":"EY Rim","year":"2022","unstructured":"Rim EY, Clevers H, Nusse R (2022) The Wnt pathway: from signaling mechanisms to synthetic modulators. Annu Rev Biochem 91:571\u2013598","journal-title":"Annu Rev Biochem"},{"key":"858_CR102","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/j.celrep.2015.10.049","volume":"13","author":"AS Rocha","year":"2015","unstructured":"Rocha AS, Vidal V, Mertz M, Kendall TJ, Charlet A, Okamoto H, Schedl A (2015) The angiocrine factor Rspondin3 is a key determinant of liver zonation. Cell Rep 13:1757\u20131764","journal-title":"Cell Rep"},{"key":"858_CR103","doi-asserted-by":"crossref","first-page":"36734","DOI":"10.1074\/jbc.274.51.36734","volume":"274","author":"S Roura","year":"1999","unstructured":"Roura S, Miravet S, Piedra J, Garc\u00eda de Herreros A, Du\u00f1ach M (1999) Regulation of E-cadherin\/Catenin association by tyrosine phosphorylation. J Biol Chem 274:36734\u201336740","journal-title":"J Biol Chem"},{"key":"858_CR104","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1158\/2159-8290.CD-19-0074","volume":"9","author":"M Ruiz de Galarreta","year":"2019","unstructured":"Ruiz de Galarreta M, Bresnahan E, Molina-S\u00e1nchez P, Lindblad KE, Maier B, Sia D, Puigvehi M, Miguela V, Casanova-Acebes M, Dhainaut M, Villacorta-Martin C, Singhi AD, Moghe A, von Felden J, Tal Grinspan L, Wang S, Kamphorst AO, Monga SP, Brown BD, Villanueva A, Llovet JM, Merad M, Lujambio A (2019) \u03b2-Catenin activation promotes immune escape and resistance to anti-PD-1 therapy in hepatocellular carcinoma. Cancer Discov 9:1124\u20131141","journal-title":"Cancer Discov"},{"key":"858_CR105","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1146\/annurev-pathol-020117-044010","volume":"13","author":"JO Russell","year":"2018","unstructured":"Russell JO, Monga SP (2018) Wnt\/\u03b2-catenin signaling in liver development, homeostasis, and pathobiology. Annu Rev Pathol 13:351\u2013378","journal-title":"Annu Rev Pathol"},{"key":"858_CR106","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/ng.3252","volume":"47","author":"K Schulze","year":"2015","unstructured":"Schulze K, Imbeaud S, Letouz\u00e9 E, Alexandrov LB, Calderaro J, Rebouissou S, Couchy G, Meiller C, Shinde J, Soysouvanh F, Calatayud AL, Pinyol R, Pelletier L, Balabaud C, Laurent A, Blanc JF, Mazzaferro V, Calvo F, Villanueva A, Nault JC, Bioulac-Sage P, Stratton MR, Llovet JM, Zucman-Rossi J (2015) Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets. Nat Genet 47:505\u2013511","journal-title":"Nat Genet"},{"key":"858_CR107","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/hep.21523","volume":"45","author":"S Sekine","year":"2007","unstructured":"Sekine S, Guti\u00e9rrez PJ, Lan BY, Feng S, Hebrok M (2007) Liver-specific loss of \u03b2-catenin results in delayed hepatocyte proliferation after partial hepatectomy. Hepatology 45:361\u2013368","journal-title":"Hepatology"},{"key":"858_CR108","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1002\/hep.21131","volume":"43","author":"S Sekine","year":"2006","unstructured":"Sekine S, Lan BY, Bedolli M, Feng S, Hebrok M (2006) Liver-specific loss of \u03b2-catenin blocks glutamine synthesis pathway activity and cytochrome p450 expression in mice. Hepatology 43:817\u2013825","journal-title":"Hepatology"},{"key":"858_CR109","doi-asserted-by":"crossref","first-page":"BSR20192466","DOI":"10.1042\/BSR20192466","volume":"39","author":"YL Sha","year":"2019","unstructured":"Sha YL, Liu S, Yan WW, Dong B (2019) Wnt\/\u03b2-catenin signaling as a useful therapeutic target in hepatoblastoma. Biosci Rep 39:BSR20192466","journal-title":"Biosci Rep"},{"key":"858_CR110","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/labinvest.3700043","volume":"84","author":"XZ Shang","year":"2004","unstructured":"Shang XZ, Zhu H, Lin K, Tu Z, Chen J, Nelson DR, Liu C (2004) Stabilized \u03b2-catenin promotes hepatocyte proliferation and inhibits TNF\u03b1-induced apoptosis. Lab Invest 84:332\u2013341","journal-title":"Lab Invest"},{"key":"858_CR111","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1002\/hep.31772","volume":"74","author":"J Shiota","year":"2021","unstructured":"Shiota J, Samuelson LC, Razumilava N (2021) Hepatobiliary organoids and their applications for studies of liver health and disease: are we there yet? Hepatology 74:2251\u20132263","journal-title":"Hepatology"},{"key":"858_CR112","doi-asserted-by":"crossref","first-page":"5522","DOI":"10.1073\/pnas.96.10.5522","volume":"96","author":"M Shtutman","year":"1999","unstructured":"Shtutman M, Zhurinsky J, Simcha I, Albanese C, D\u2019Amico M, Pestell R, Ben-Ze\u2019ev A (1999) The cyclin D1 gene is a target of the \u03b2-catenin\/LEF-1 pathway. Proc Natl Acad Sci U S A 96:5522\u20135527","journal-title":"Proc Natl Acad Sci U S A"},{"key":"858_CR113","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1053\/j.gastro.2017.06.007","volume":"153","author":"D Sia","year":"2017","unstructured":"Sia D, Jiao Y, Martinez-Quetglas I, Kuchuk O, Villacorta-Martin C, Castro de Moura M, Putra J, Camprecios G, Bassaganyas L, Akers N, Losic B, Waxman S, Thung SN, Mazzaferro V, Esteller M, Friedman SL, Schwartz M, Villanueva A, Llovet JM (2017) Identification of an immune-specific class of hepatocellular carcinoma, based on molecular features. Gastroenterology 153:812\u2013826","journal-title":"Gastroenterology"},{"key":"858_CR114","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21708","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A (2022) Cancer statistics, 2022. CA Cancer J Clin 72:7\u201333","journal-title":"CA Cancer J Clin"},{"key":"858_CR115","doi-asserted-by":"crossref","first-page":"e421","DOI":"10.1038\/emm.2017.174","volume":"50","author":"BH Sohn","year":"2018","unstructured":"Sohn BH, Park IY, Shin JH, Yim SY, Lee JS (2018) Glutamine synthetase mediates sorafenib sensitivity in \u03b2-catenin-active hepatocellular carcinoma cells. Exp Mol Med 50:e421","journal-title":"Exp Mol Med"},{"key":"858_CR116","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/hep.21456","volume":"45","author":"VS Stanulovi\u0107","year":"2007","unstructured":"Stanulovi\u0107 VS, Kyrmizi I, Kruithof-de Julio M, Hoogenkamp M, Vermeulen JL, Ruijter JM, Talianidis I, Hakvoort TB, Lamers WH (2007) Hepatic HNF4\u03b1 deficiency induces periportal expression of glutamine synthetase and other pericentral enzymes. Hepatology 45:433\u2013444","journal-title":"Hepatology"},{"key":"858_CR117","doi-asserted-by":"crossref","first-page":"dev146589","DOI":"10.1242\/dev.146589","volume":"145","author":"Z Steinhart","year":"2018","unstructured":"Steinhart Z, Angers S (2018) Wnt signaling in development and tissue homeostasis. Development 145:dev146589","journal-title":"Development"},{"key":"858_CR118","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1007\/s00535-008-2170-0","volume":"43","author":"H Takagi","year":"2008","unstructured":"Takagi H, Sasaki S, Suzuki H, Toyota M, Maruyama R, Nojima M, Yamamoto H, Omata M, Tokino T, Imai K, Shinomura Y (2008) Frequent epigenetic inactivation of SFRP genes in hepatocellular carcinoma. J Gastroenterol 43:378\u2013389","journal-title":"J Gastroenterol"},{"key":"858_CR119","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature12271","volume":"499","author":"T Takebe","year":"2013","unstructured":"Takebe T, Sekine K, Enomura M, Koike H, Kimura M, Ogaeri T, Zhang RR, Ueno Y, Zheng YW, Koike N, Aoyama S, Adachi Y, Taniguchi H (2013) Vascularized and functional human liver from an iPSC-derived organ bud transplant. Nature 499:481\u2013484","journal-title":"Nature"},{"key":"858_CR120","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1016\/j.celrep.2017.11.005","volume":"21","author":"T Takebe","year":"2017","unstructured":"Takebe T, Sekine K, Kimura M, Yoshizawa E, Ayano S, Koido M, Funayama S, Nakanishi N, Hisai T, Kobayashi T, Kasai T, Kitada R, Mori A, Ayabe H, Ejiri Y, Amimoto N, Yamazaki Y, Ogawa S, Ishikawa M, Kiyota Y, Sato Y, Nozawa K, Okamoto S, Ueno Y, Taniguchi H (2017) Massive and reproducible production of liver buds entirely from human pluripotent stem cells. Cell Rep 21:2661\u20132670","journal-title":"Cell Rep"},{"key":"858_CR121","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S1097-2765(03)00484-2","volume":"13","author":"K Tamai","year":"2004","unstructured":"Tamai K, Zeng X, Liu C, Zhang X, Harada Y, Chang Z, He X (2004) A mechanism for Wnt coreceptor activation. Mol Cell 13:149\u2013156","journal-title":"Mol Cell"},{"key":"858_CR122","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1053\/j.gastro.2006.08.042","volume":"131","author":"X Tan","year":"2006","unstructured":"Tan X, Behari J, Cieply B, Michalopoulos GK, Monga SP (2006) Conditional deletion of \u03b2-catenin reveals its role in liver growth and regeneration. Gastroenterology 131:1561\u20131572","journal-title":"Gastroenterology"},{"key":"858_CR123","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1002\/hep.22225","volume":"47","author":"X Tan","year":"2008","unstructured":"Tan X, Yuan Y, Zeng G, Apte U, Thompson MD, Cieply B, Stolz DB, Michalopoulos GK, Kaestner KH, Monga SP (2008) \u03b2-Catenin deletion in hepatoblasts disrupts hepatic morphogenesis and survival during mouse development. Hepatology 47:1667\u20131679","journal-title":"Hepatology"},{"key":"858_CR124","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s13046-016-0344-9","volume":"35","author":"B Tang","year":"2016","unstructured":"Tang B, Tang F, Wang Z, Qi G, Liang X, Li B, Yuan S, Liu J, Yu S, He S (2016) Overexpression of CTNND1 in hepatocellular carcinoma promotes carcinous characters through activation of Wnt\/\u03b2-catenin signaling. J Exp Clin Cancer Res 35:82","journal-title":"J Exp Clin Cancer Res"},{"key":"858_CR125","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1053\/j.gastro.2014.05.004","volume":"147","author":"J Tao","year":"2014","unstructured":"Tao J, Calvisi DF, Ranganathan S, Cigliano A, Zhou L, Singh S, Jiang L, Fan B, Terracciano L, Armeanu-Ebinger S, Ribback S, Dombrowski F, Evert M, Chen X, Monga SPS (2014) Activation of \u03b2-catenin and Yap1 in human hepatoblastoma and induction of hepatocarcinogenesis in mice. Gastroenterology 147:690\u2013701","journal-title":"Gastroenterology"},{"key":"858_CR126","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1002\/hep.31730","volume":"74","author":"J Tao","year":"2021","unstructured":"Tao J, Krutsenko Y, Moghe A, Singh S, Poddar M, Bell A, Oertel M, Singhi AD, Geller D, Chen X, Lujambio A, Liu S, Monga SP (2021) Nuclear factor erythroid 2-related factor 2 and \u03b2-catenin coactivation in hepatocellular cancer: biological and therapeutic implications. Hepatology 74:741\u2013759","journal-title":"Hepatology"},{"key":"858_CR127","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1002\/hep.28601","volume":"64","author":"J Tao","year":"2016","unstructured":"Tao J, Xu E, Zhao Y, Singh S, Li X, Couchy G, Chen X, Zucman-Rossi J, Chikina M, Monga SP (2016) Modeling a human hepatocellular carcinoma subset in mice through coexpression of met and point-mutant \u03b2-catenin. Hepatology 64:1587\u20131605","journal-title":"Hepatology"},{"key":"858_CR128","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/18884","volume":"398","author":"O Tetsu","year":"1999","unstructured":"Tetsu O, McCormick F (1999) \u03b2-Catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 398:422\u2013426","journal-title":"Nature"},{"key":"858_CR129","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1002\/hep.30631","volume":"70","author":"A Thakur","year":"2019","unstructured":"Thakur A, Wong JCH, Wang EY, Lotto J, Kim D, Cheng JC, Mingay M, Cullum R, Moudgil V, Ahmed N, Tsai SH, Wei W, Walsh CP, Stephan T, Bilenky M, Fuglerud BM, Karimi MM, Gonzalez FJ, Hirst M, Hoodless PA (2019) Hepatocyte nuclear factor 4-\u03b1 is essential for the active epigenetic state at enhancers in mouse liver. Hepatology 70:1360\u20131376","journal-title":"Hepatology"},{"key":"858_CR130","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jhep.2010.10.021","volume":"55","author":"C Torre","year":"2011","unstructured":"Torre C, Benhamouche S, Mitchell C, Godard C, Veber P, Letourneur F, Cagnard N, Jacques S, Finzi L, Perret C, Colnot S (2011) The transforming growth factor-\u03b1 and cyclin D1 genes are direct targets of \u03b2-catenin signaling in hepatocyte proliferation. J Hepatol 55:86\u201395","journal-title":"J Hepatol"},{"key":"858_CR131","doi-asserted-by":"crossref","first-page":"re9","DOI":"10.1126\/scisignal.135re9","volume":"1","author":"R van Amerongen","year":"2008","unstructured":"van Amerongen R, Mikels A, Nusse R (2008) Alternative wnt signaling is initiated by distinct receptors. Sci Signal 1:re9","journal-title":"Sci Signal"},{"key":"858_CR132","doi-asserted-by":"crossref","first-page":"G26","DOI":"10.1152\/ajpgi.00064.2012","volume":"304","author":"C Walesky","year":"2013","unstructured":"Walesky C, Gunewardena S, Terwilliger EF, Edwards G, Borude P, Apte U (2013) Hepatocyte-specific deletion of hepatocyte nuclear factor-4\u03b1 in adult mice results in increased hepatocyte proliferation. Am J Physiol Gastrointest Liver Physiol 304:G26-37","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"858_CR133","doi-asserted-by":"crossref","first-page":"5785","DOI":"10.1038\/s41467-020-19558-3","volume":"11","author":"CM Walesky","year":"2020","unstructured":"Walesky CM, Kolb KE, Winston CL, Henderson J, Kruft B, Fleming I, Ko S, Monga SP, Mueller F, Apte U, Shalek AK, Goessling W (2020) Functional compensation precedes recovery of tissue mass following acute liver injury. Nat Commun 11:5785","journal-title":"Nat Commun"},{"key":"858_CR134","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/26785","volume":"395","author":"L Waltzer","year":"1998","unstructured":"Waltzer L, Bienz M (1998) Drosophila CBP represses the transcription factor TCF to antagonize Wingless signalling. Nature 395:521\u2013525","journal-title":"Nature"},{"key":"858_CR135","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/nature14863","volume":"524","author":"B Wang","year":"2015","unstructured":"Wang B, Zhao L, Fish M, Logan CY, Nusse R (2015) Self-renewing diploid Axin2(+) cells fuel homeostatic renewal of the liver. Nature 524:180\u2013185","journal-title":"Nature"},{"key":"858_CR136","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1093\/carcin\/bgu180","volume":"35","author":"J Wang","year":"2014","unstructured":"Wang J, Zhu CP, Hu PF, Qian H, Ning BF, Zhang Q, Chen F, Liu J, Shi B, Zhang X, Xie WF (2014) FOXA2 suppresses the metastasis of hepatocellular carcinoma partially through matrix metalloproteinase-9 inhibition. Carcinogenesis 35:2576\u20132583","journal-title":"Carcinogenesis"},{"key":"858_CR137","doi-asserted-by":"crossref","first-page":"936","DOI":"10.3892\/mco.2015.569","volume":"3","author":"Z Wang","year":"2015","unstructured":"Wang Z, Sheng YY, Gao XM, Wang CQ, Wang XY, Lu XU, Wei JW, Zhang KL, Dong QZ, Qin LX (2015) \u03b2-catenin mutation is correlated with a favorable prognosis in patients with hepatocellular carcinoma. Mol Clin Oncol 3:936\u2013940","journal-title":"Mol Clin Oncol"},{"key":"858_CR138","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1002\/ijc.24810","volume":"126","author":"W Wei","year":"2010","unstructured":"Wei W, Chua MS, Grepper S, So S (2010) Small molecule antagonists of Tcf4\/\u03b2-catenin complex inhibit the growth of HCC cells in vitro and in vivo. Int J Cancer 126:2426\u20132436","journal-title":"Int J Cancer"},{"key":"858_CR139","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0959-437X(98)80068-3","volume":"8","author":"K Willert","year":"1998","unstructured":"Willert K, Nusse R (1998) \u03b2-catenin: a key mediator of Wnt signaling. Curr Opin Genet Dev 8:95\u2013102","journal-title":"Curr Opin Genet Dev"},{"key":"858_CR140","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/ijc.28697","volume":"135","author":"Q Xie","year":"2014","unstructured":"Xie Q, Chen L, Shan X, Shan X, Tang J, Zhou F, Chen Q, Quan H, Nie D, Zhang W, Huang AL, Tang N (2014) Epigenetic silencing of SFRP1 and SFRP5 by hepatitis B virus X protein enhances hepatoma cell tumorigenicity through Wnt signaling pathway. Int J Cancer 135:635\u2013646","journal-title":"Int J Cancer"},{"key":"858_CR141","doi-asserted-by":"crossref","first-page":"e154515","DOI":"10.1172\/JCI154515","volume":"132","author":"C Xu","year":"2022","unstructured":"Xu C, Xu Z, Zhang Y, Evert M, Calvisi DF, Chen X (2022) \u03b2-Catenin signaling in hepatocellular carcinoma. J Clin Invest 132:e154515","journal-title":"J Clin Invest"},{"key":"858_CR142","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1002\/cbic.201200506","volume":"13","author":"A Yahara","year":"2012","unstructured":"Yahara A, Shrestha AR, Yamamoto T, Hari Y, Osawa T, Yamaguchi M, Nishida M, Kodama T, Obika S (2012) Amido-bridged nucleic acids (AmNAs): synthesis, duplex stability, nuclease resistance, and in vitro antisense potency. ChemBioChem 13:2513\u20132516","journal-title":"ChemBioChem"},{"key":"858_CR143","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1177\/1535370217708198","volume":"242","author":"M Yan","year":"2017","unstructured":"Yan M, Li G, An J (2017) Discovery of small molecule inhibitors of the Wnt\/\u03b2-catenin signaling pathway by targeting \u03b2-catenin\/Tcf4 interactions. Exp Biol Med (maywood) 242:1185\u20131197","journal-title":"Exp Biol Med (maywood)"},{"key":"858_CR144","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/hep.27082","volume":"60","author":"J Yang","year":"2014","unstructured":"Yang J, Mowry LE, Nejak-Bowen KN, Okabe H, Diegel CR, Lang RA, Williams BO, Monga SP (2014) \u03b2-catenin signaling in murine liver zonation and regeneration: a Wnt-Wnt situation! Hepatology 60:964\u2013976","journal-title":"Hepatology"},{"key":"858_CR145","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/s41419-018-0818-0","volume":"9","author":"Y Yang","year":"2018","unstructured":"Yang Y, Ye YC, Chen Y, Zhao JL, Gao CC, Han H, Liu WC, Qin HY (2018) Crosstalk between hepatic tumor cells and macrophages via Wnt\/\u03b2-catenin signaling promotes M2-like macrophage polarization and reinforces tumor malignant behaviors. Cell Death Dis 9:793","journal-title":"Cell Death Dis"},{"key":"858_CR146","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.1158\/0008-5472.CAN-18-1691","volume":"79","author":"YC Ye","year":"2019","unstructured":"Ye YC, Zhao JL, Lu YT, Gao CC, Yang Y, Liang SQ, Lu YY, Wang L, Yue SQ, Dou KF, Qin HY, Han H (2019) NOTCH signaling via WNT regulates the proliferation of alternative, CCR2-independent tumor-associated macrophages in hepatocellular carcinoma. Cancer Res 79:4160\u20134172","journal-title":"Cancer Res"},{"key":"858_CR147","doi-asserted-by":"crossref","first-page":"3620","DOI":"10.1016\/j.yexcr.2006.08.003","volume":"312","author":"G Zeng","year":"2006","unstructured":"Zeng G, Apte U, Micsenyi A, Bell A, Monga SP (2006) Tyrosine residues 654 and 670 in \u03b2-catenin are crucial in regulation of Met-\u03b2-catenin interactions. Exp Cell Res 312:3620\u20133630","journal-title":"Exp Cell Res"}],"container-title":["In Vitro Cellular & Developmental Biology - Animal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11626-024-00858-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11626-024-00858-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11626-024-00858-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T18:23:57Z","timestamp":1716575037000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11626-024-00858-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,20]]},"references-count":147,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["858"],"URL":"https:\/\/doi.org\/10.1007\/s11626-024-00858-7","relation":{},"ISSN":["1071-2690","1543-706X"],"issn-type":[{"value":"1071-2690","type":"print"},{"value":"1543-706X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,20]]},"assertion":[{"value":"13 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}